首页 | 本学科首页   官方微博 | 高级检索  
     

631例血塞通注射液不良反应/事件报告分析
引用本文:李文武,张惠霞,杨莎莎,刘超. 631例血塞通注射液不良反应/事件报告分析[J]. 中国药物警戒, 2010, 7(11): 690-693
作者姓名:李文武  张惠霞  杨莎莎  刘超
作者单位:1. 河南省食品药品评价中心,河南,郑州,450004
2. 河南大学药学院,河南,开封,475004
摘    要:目的通过探讨血塞通注射液不良反应发生的一般规律和特点,为临床合理用药提供参考。方法采用回顾性研究方法,对2004~2009年我中心收集的631例血塞通注射液药品不良反应/事件报告进行统计分析。结果 60岁以上的患者259例,占41.05%;药品不良反应发生时间在30分钟以内的患者233例,占36.93%;超剂量用药186例,占29.48%;联合用药125例,占19.81%;不良反应主要表现为皮肤损害。结论应加强对血塞通注射液的监测,提高临床合理用药水平,减少不良反应的发生。

关 键 词:血塞通注射液  药品不良反应/事件  分析

Analysis of 631 Reports of ADR/ADE Caused by Xuesaitong Injection
LI Wen-wu,ZHANG Hui-xia,YANG Sha-sha,LIU Chao. Analysis of 631 Reports of ADR/ADE Caused by Xuesaitong Injection[J]. Chinese JOurnal of Pharmacovigilance, 2010, 7(11): 690-693
Authors:LI Wen-wu  ZHANG Hui-xia  YANG Sha-sha  LIU Chao
Affiliation:(Henan Center for Drug Reevaluation,Henan Zhenzhou 450004;Pharmaceutical College of Henan University,Henan Kaifeng,475004)
Abstract:Objective To study the general pattern and characteristics of adverse drug reactions induced by Xuesaitong injection to provide references for clinical rational use of drug.Methods 631 ADR/ADE reports of Xuesaitong injection collected by Henan center for ADR monitoring from 2004 to 2009 were analyzed using retrospective study method.Results 259 cases of patients over the age of 60 accounted for 41.05%;233 cases of patients with ADR/ ADE occurred within 30 minutes accounted for 36.93%;186 cases of drug overdose accounted for 29.48%;125 cases of combination therapy accounted for 19.81%;ADR/ADE mainly were skin allergies.Conclusion ADR monitoring should be strengthened to improve the rational use of drug and reduce the occurrence of ADR/ADE.
Keywords:Xuesaitong injection  adverse drug reaction/event(ADR/ADE)  analysis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号